Mia Levy
Faculty Member
Last active: 6/11/2014

  1. Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling. Abramson VG, Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL (2014) Breast Cancer Res Treat 145(2): 389-99
    › Primary publication · 24722917 (PubMed) · PMC4046906 (PubMed Central)
  2. Beyond histology: translating tumor genotypes into clinically effective targeted therapies. Meador CB, Micheel CM, Levy MA, Lovly CM, Horn L, Warner JL, Johnson DB, Zhao Z, Anderson IA, Sosman JA, Vnencak-Jones CL, Dahlman KB, Pao W (2014) Clin Cancer Res 20(9): 2264-75
    › Primary publication · 24599935 (PubMed) · PMC4008689 (PubMed Central)
  3. An informatics-enabled approach for detection of new tumor registry cases. Naser R, Roberts J, Salter T, Warner JL, Levy M (2014) J Registry Manag 41(1): 19-23
    › Primary publication · 24893184 (PubMed)
  4. Scalable Data-driven Phenotypes via Unsupervised Feature Learning. Lasko TA, Denny JC, Levy MA (2013) AMIA Jt Summits Transl Sci Proc : 106
    › Primary publication · 24303314 (PubMed) · PMC3814458 (PubMed Central)
  5. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM (2013) Am J Clin Pathol 140(5): 643-50
    › Primary publication · 24124142 (PubMed) · PMC4159763 (PubMed Central)
  6. Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy. Mani S, Chen Y, Li X, Arlinghaus L, Chakravarthy AB, Abramson V, Bhave SR, Levy MA, Xu H, Yankeelov TE (2013) J Am Med Inform Assoc 20(4): 688-95
    › Primary publication · 23616206 (PubMed) · PMC3721158 (PubMed Central)
  7. Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data. Lasko TA, Denny JC, Levy MA (2013) PLoS One 8(6): e66341
    › Primary publication · 23826094 (PubMed) · PMC3691199 (PubMed Central)
  8. Clinical analysis and interpretation of cancer genome data. Van Allen EM, Wagle N, Levy MA (2013) J Clin Oncol 31(15): 1825-33
    › Primary publication · 23589549 (PubMed) · PMC4878102 (PubMed Central)
  9. Applying bar code medication administration to make a difference in adverse drug events with potential for harm: lessons learned. FitzHenry F, Wells N, Doran J, Hughart K, Levy M, Doulis J (2013) Comput Inform Nurs 31(10): 457-62
    › Primary publication · 24135882 (PubMed)
  10. Translating genomic information into clinical medicine: lung cancer as a paradigm. Levy MA, Lovly CM, Pao W (2012) Genome Res 22(11): 2101-8
    › Primary publication · 23019146 (PubMed) · PMC3483539 (PubMed Central)